Wittman V - Search Results

1

An immunologic model for rapid vaccine assessment -- a clinical trial in a test tube.

Higbee RG, Byers AM, Dhir V, Drake D, Fahlenkamp HG, Gangur J, Kachurin A, Kachurina O, Leistritz D, Ma Y, Mehta R, Mishkin E, Moser J, Mosquera L, Nguyen M, Parkhill R, Pawar S, Poisson L, Sanchez-Schmitz G, Schanen B, Singh I, Song H, Tapia T, Warren W, Wittman V. Higbee RG, et al. Among authors: wittman v. Altern Lab Anim. 2009 Sep;37 Suppl 1:19-27. doi: 10.1177/026119290903701S05. Altern Lab Anim. 2009. PMID: 19807200

2

In vitro antibody response to tetanus in the MIMIC system is a representative measure of vaccine immunogenicity.

Byers AM, Tapia TM, Sassano ER, Wittman V. Byers AM, et al. Among authors: wittman v. Biologicals. 2009 Jun;37(3):148-51. doi: 10.1016/j.biologicals.2009.02.018. Epub 2009 Mar 9. Biologicals. 2009. PMID: 19272794

3

New tests for an old foe: an update on influenza screening.

Wittman V, Byers A, Drake D, Kachurina O, Tapia T, Warren W, Kachurin A. Wittman V, et al. IDrugs. 2010 Apr;13(4):248-53. IDrugs. 2010. PMID: 20373254 Review.

4

A predictive biomimetic model of cytokine release induced by TGN1412 and other therapeutic monoclonal antibodies.

Dhir V, Fort M, Mahmood A, Higbee R, Warren W, Narayanan P, Wittman V. Dhir V, et al. Among authors: wittman v. J Immunotoxicol. 2012 Jan-Mar;9(1):34-42. doi: 10.3109/1547691X.2011.613419. Epub 2011 Nov 10. J Immunotoxicol. 2012. PMID: 22074378

5

Coupling sensitive in vitro and in silico techniques to assess cross-reactive CD4(+) T cells against the swine-origin H1N1 influenza virus.

Schanen BC, De Groot AS, Moise L, Ardito M, McClaine E, Martin W, Wittman V, Warren WL, Drake DR 3rd. Schanen BC, et al. Among authors: wittman v. Vaccine. 2011 Apr 12;29(17):3299-309. doi: 10.1016/j.vaccine.2011.02.019. Epub 2011 Feb 22. Vaccine. 2011. PMID: 21349362 Free PMC article.

6

In vitro stimulation of human influenza-specific CD8+ T cells by dendritic cells pulsed with an influenza virus-like particle (VLP) vaccine.

Song H, Wittman V, Byers A, Tapia T, Zhou B, Warren W, Heaton P, Connolly K. Song H, et al. Among authors: wittman v. Vaccine. 2010 Aug 2;28(34):5524-32. doi: 10.1016/j.vaccine.2010.06.044. Epub 2010 Jun 25. Vaccine. 2010. PMID: 20600506

7

Adjuvant effects of a sequence-engineered mRNA vaccine: translational profiling demonstrates similar human and murine innate response.

Edwards DK, Jasny E, Yoon H, Horscroft N, Schanen B, Geter T, Fotin-Mleczek M, Petsch B, Wittman V. Edwards DK, et al. Among authors: wittman v. J Transl Med. 2017 Jan 3;15(1):1. doi: 10.1186/s12967-016-1111-6. J Transl Med. 2017. PMID: 28049494 Free PMC article.

8

Antibody targeting to a class I MHC-peptide epitope promotes tumor cell death.

Wittman VP, Woodburn D, Nguyen T, Neethling FA, Wright S, Weidanz JA. Wittman VP, et al. J Immunol. 2006 Sep 15;177(6):4187-95. doi: 10.4049/jimmunol.177.6.4187. J Immunol. 2006. PMID: 16951384

9

Acute effect of high glucose on long-term cell growth: a role for transient glucose increase in proximal tubule cell injury.

Samikkannu T, Thomas JJ, Bhat GJ, Wittman V, Thekkumkara TJ. Samikkannu T, et al. Among authors: wittman v. Am J Physiol Renal Physiol. 2006 Jul;291(1):F162-75. doi: 10.1152/ajprenal.00189.2005. Epub 2006 Feb 7. Am J Physiol Renal Physiol. 2006. PMID: 16467130 Free article.

10

ATR blockade reduces IFN-gamma production in lymphocytes in vivo and in vitro.

Weidanz JA, Jacobson LM, Muehrer RJ, Djamali A, Hullett DA, Sprague J, Chiriva-Internati M, Wittman V, Thekkumkara TJ, Becker BN. Weidanz JA, et al. Among authors: wittman v. Kidney Int. 2005 Jun;67(6):2134-42. doi: 10.1111/j.1523-1755.2005.00318.x. Kidney Int. 2005. PMID: 15882256 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page